{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"100"},{"groupId":"OG001","value":"57.1"},{"groupId":"OG002","value":"55.0"},{"groupId":"OG003","value":"55.3"}]}],"title":"QTcB >450 msec"},{"categories":[{"measurements":[{"groupId":"OG000","value":"66.7"},{"groupId":"OG001","value":"28.6"},{"groupId":"OG002","value":"0.0"},{"groupId":"OG003","value":"4.3"}]}],"title":"QTcB >480 msec"},{"categories":[{"measurements":[{"groupId":"OG000","value":"33.3"},{"groupId":"OG001","value":"14.3"},{"groupId":"OG002","value":"0.0"},{"groupId":"OG003","value":"2.1"}]}],"title":"QTcB >500 msec"},{"categories":[{"measurements":[{"groupId":"OG000","value":"66.7"},{"groupId":"OG001","value":"57.1"},{"groupId":"OG002","value":"10.0"},{"groupId":"OG003","value":"17.0"}]}],"title":"QTcB increase from predose >30 msec"},{"categories":[{"measurements":[{"groupId":"OG000","value":"33.3"},{"groupId":"OG001","value":"28.6"},{"groupId":"OG002","value":"0.0"},{"groupId":"OG003","value":"4.3"}]}],"title":"QTcB increase from predose >60 msec"},{"categories":[{"measurements":[{"groupId":"OG000","value":"33.3"},{"groupId":"OG001","value":"14.3"},{"groupId":"OG002","value":"10.0"},{"groupId":"OG003","value":"10.6"}]}],"title":"QTcF >450 msec"},{"categories":[{"measurements":[{"groupId":"OG000","value":"33.3"},{"groupId":"OG001","value":"14.3"},{"groupId":"OG002","value":"0.0"},{"groupId":"OG003","value":"2.1"}]}],"title":"QTcF >480 msec"},{"categories":[{"measurements":[{"groupId":"OG000","value":"33.3"},{"groupId":"OG001","value":"14.3"},{"groupId":"OG002","value":"0.0"},{"groupId":"OG003","value":"2.1"}]}],"title":"QTcF >500 msec"},{"categories":[{"measurements":[{"groupId":"OG000","value":"66.7"},{"groupId":"OG001","value":"57.1"},{"groupId":"OG002","value":"10.0"},{"groupId":"OG003","value":"17.0"}]}],"title":"QTcF increase from predose >30 msec"},{"categories":[{"measurements":[{"groupId":"OG000","value":"33.3"},{"groupId":"OG001","value":"14.3"},{"groupId":"OG002","value":"0.0"},{"groupId":"OG003","value":"2.1"}]}],"title":"QTcF increase from predose >60 msec"}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"40"},{"groupId":"OG003","value":"47"}],"units":"Participants"}],"description":"The time from the start of the Q-wave to the end of the T-wave QTc intervals greater than 450 msec post-baseline performed by centralized reviewer. The Bazett's (QTcB) and Fridericia (QTcF) correction were used as the standard clinical correction for calculating the heart rate-corrected QTc interval","groups":[{"description":"Romidepsin 9mg/m\\^2 by intravenous (IV) infusion on Days 1, 8, 15 of each 28-day cycle","id":"OG000","title":"Phase 1: Romidepsin 9mg/m^2"},{"description":"Romidepsin 14mg/m\\^2 by intravenous (IV) infusion on Days 1, 8, 15 of each 28-day cycle.","id":"OG001","title":"Phase 1: Romidepsin 14mg/m^2"},{"description":"Romidepsin 14mg/m\\^2 by intravenous (IV) infusion on Days 1, 8, 15 of each 28-day cycle.","id":"OG002","title":"Phase 2: Romidepsin 14mg/m^2"},{"description":"Romidepsin 14mg/m\\^2 by intravenous (IV) infusion on Days 1, 8, 15 of each 28-day cycle.","id":"OG003","title":"Total: Romidepsin 14mg/m^2"}],"paramType":"NUMBER","populationDescription":"The ECG population includes all participants who received romidepsin on Day 1 of Cycle 1 with at least one post-baseline QTc result","reportingStatus":"POSTED","timeFrame":"Median follow-up: 100 days; up to data cut-off of 28 July 2015","title":"The Percentage of Participants With Abnormal Q-wave and T Wave Intervals","type":"SECONDARY","unitOfMeasure":"percentage of participants"}